Lawmakers complain about proposed limits to warning labels

01/24/2008 | Star-Ledger (Newark, N.J.), The

An FDA proposal to restrict the addition of warnings to product labels would further delay informing the public about the potential dangers of drugs or medical devices, a group of House and Senate Democrats said in a letter to Commissioner Andrew von Eschenbach. "It is apparently designed to bolster the argument by companies defending against lawsuits that the regulations precluded them from adding contraindications, warnings, precautions and adverse reactions in the absence of FDA approval," the lawmakers stated.

View Full Article in:

Star-Ledger (Newark, N.J.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC